These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5149486)

  • 41. Proceedings: Trypsin-like enzymes and trypsin inhibitors.
    Levinsky H; Smirnoff P; Khalef S; Birk Y; Applebaum SW
    Isr J Med Sci; 1975 Nov; 11(11):1170. PubMed ID: 1205732
    [No Abstract]   [Full Text] [Related]  

  • 42. [Studies on the binding of I-131 insulin to serum proteins].
    Geerling H; Sirek OV
    Verh Dtsch Ges Inn Med; 1965; 71():347-50. PubMed ID: 5877635
    [No Abstract]   [Full Text] [Related]  

  • 43. [Low-molecular cytolysins and trypsin inhibitors from sea anemone Radianthus macrodactylus. Isolation and partial characterization].
    Zykova TA; Monastyrnaia MM; Apalikova OV; Shvets TV; Kozlovskaia EP
    Bioorg Khim; 1998 Jul; 24(7):509-16. PubMed ID: 9749312
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A high-molecular-weight trypsinlike protease in the skin sites of delayed hypersensitivity in guinea pigs.
    Nakamura T; Yamamoto T; Ishimatsu T; Kambara T
    Am J Pathol; 1984 Feb; 114(2):250-63. PubMed ID: 6198919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relation of the urinary cancer-related glycoprotein EDC1 to plasma inter-alpha-trypsin inhibitor.
    Chawla RK; Wadsworth AD; Rudman D
    J Immunol; 1978 Nov; 121(5):1636-9. PubMed ID: 101589
    [No Abstract]   [Full Text] [Related]  

  • 46. Characterization of glucagon-like immunoreactivity (GLI).
    Valverde I; Rigopoulou D; Marco J; Faloona GR; Unger RH
    Diabetes; 1970 Sep; 19(9):614-23. PubMed ID: 4990293
    [No Abstract]   [Full Text] [Related]  

  • 47. [Human urinary trypsin inhibitor. III. Investigation of plasma protein which reacts with an antiserum against urinary trypsin inhibitor].
    Maehara S
    Nihon Hinyokika Gakkai Zasshi; 1983 Sep; 74(9):1653-60. PubMed ID: 6676591
    [No Abstract]   [Full Text] [Related]  

  • 48. The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement.
    Lachmann PJ; Müller-Eberhard HJ
    J Immunol; 1968 Apr; 100(4):691-8. PubMed ID: 5645214
    [No Abstract]   [Full Text] [Related]  

  • 49. Insights into the function of a sperm-surface progesterone receptor: evidence of ligand-induced receptor aggregation and the implication of proteolysis.
    Tesarik J; Mendoza C
    Exp Cell Res; 1993 Mar; 205(1):111-7. PubMed ID: 8453985
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Purification and some properties of a plasma protein which reacts with an antiserum against urinary trypsin inhibitor-1.
    Maehara S; Kawashita E; Sumi H; Toki N
    Scand J Clin Lab Invest; 1983 Feb; 43(1):21-6. PubMed ID: 6194553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions of Bacillus subtilis alkaline proteinases with alpha 2 -macroglobulin and alpha 1 -antitrypsin.
    Wicher V; Dolovich J
    Int Arch Allergy Appl Immunol; 1971; 40(6):779-88. PubMed ID: 4998094
    [No Abstract]   [Full Text] [Related]  

  • 52. [Interaction of trypsin with inhibitors of human blood serum].
    Shaternikov VA; Kniazev II
    Vopr Med Khim; 1966; 12(5):496-502. PubMed ID: 4174762
    [No Abstract]   [Full Text] [Related]  

  • 53. [The effect of synthetic trypsin inhibitors on the kinin-liberating effect of trypsin and pancreatic kallikrein].
    Markwardt F; Walsmann P; Drawert J
    Acta Biol Med Ger; 1970; 24(3):401-4. PubMed ID: 5510483
    [No Abstract]   [Full Text] [Related]  

  • 54. [Some properties of high molecular products of the trypsin fibrinogen hydrolysis].
    Belitser VA; Varetskaia TV; Tsinkalovskaia SN; Pozdniakova TM; Orlovskaia NN
    Ukr Biokhim Zh; 1970; 42(2):165-74. PubMed ID: 5511468
    [No Abstract]   [Full Text] [Related]  

  • 55. On the physiological role of 2 -macroglobulin.
    Rinderknecht H; Geokas MC
    Biochim Biophys Acta; 1973 Jan; 295(1):233-44. PubMed ID: 4346434
    [No Abstract]   [Full Text] [Related]  

  • 56. Specific calcitonin-binding proteins in man.
    Milhaud G; Szlamka I
    Experientia; 1971; 27(11):1335-6. PubMed ID: 5134303
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood volume and plasma protein. II. Changes in blood volume and plasma proteins after bleeding and immediate substitution with physiologic saline, dog plasma and dog albumin in the splenectomized dog.
    Rieger A
    Acta Chir Scand Suppl; 1967; 379():5-21. PubMed ID: 5243640
    [No Abstract]   [Full Text] [Related]  

  • 59. [Purification and properties of inhibitor from vegetative portion of alfalfa].
    Sukhinin VN; Berezin VA; Novikov IuF; Reva AD; Lagutenko AV
    Biokhimiia; 1981 Jul; 46(7):1183-7. PubMed ID: 7272346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [On protease inhibitors. II. Isolation and characterization of protease inhibitors from the neck of the pancreas of several vertebrates and man].
    Fritz H; Woitinas F; Werle E
    Hoppe Seylers Z Physiol Chem; 1966; 345(2):168-80. PubMed ID: 5989601
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.